Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study

Journal of Human Hypertension volume 21, pages 795–801 (2007)Cite this article

Abstract

Aims of this study were to investigate the prevalence of metabolic syndrome (MS), diagnosed according to the International Diabetes Federation (IDF) criteria and its relationship with echocardiographic parameters of cardiac structure and function. The study was performed in 707 subjects, age 45–54 years, of the Gubbio Population Study who underwent a comprehensive examination including measurement of body size, blood pressure (BP) and heart rate, 12-lead electrocardiogram, Doppler echocardiography, standardized blood and urine laboratory tests. One hundred and fifty-three subjects were found to have MS, which was more frequent among hypertensive patients than normotensive controls (36.2 vs 13.7%, P<0.001). Apart from visceral obesity present in all subjects by definition according to the IDF criteria, high levels of BP (>130/85 mm Hg) and triglycerides (⩾150 mg/dl) were the most frequently observed components of the syndrome, since their prevalence averaged 75% of those with the syndrome. Left ventricular mass (95.6±22 vs 86.4±22 g/m2; P<0.001) and prevalence of left ventricular hypertrophy were increased in the subgroup with MS. Waist circumference, BP and blood glucose were the components of the syndrome with stronger impact on cardiac mass. An early impairment of the diastolic function was detected in this subgroup with a reduction of the early-to-late diastolic filling (0.91±0.17 vs 0.99±0.23, P<0.001). The results of the present study indicate that MS is frequent in middle-aged general population, particularly in subjects with arterial hypertension. The syndrome is associated to the increase in ventricular mass and the early impairment of diastolic function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 2: 1011–1053.

  2. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.

    Article  CAS  Google Scholar 

  3. Alberti KG, Zimmet P, Shaw J, IDF epidemiology task force consensus group. The metabolic syndrome – a new worldwide definition. Lancet 2005; 366: 1059–1062.

    Article  Google Scholar 

  4. Laurezi M, Cirillo M, Angeletti M, Buongiorno A, Morisi G, Panarelli W et al. Gubbio Population Study: baseline findings. Nutr Met Cardiovasc Dis 1991; 1: S1–S18.

    Google Scholar 

  5. Laurenzi M, Trevisan M . Sodium-lithium countertransport and blood pressure: the Gubbio Population Study. Hypertension 1989; 13: 408–415.

    Article  CAS  Google Scholar 

  6. Durnin JV, Womersley J . Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974; 32: 77–97.

    Article  CAS  Google Scholar 

  7. Sahn DJ, De Maria A, Kisslo J, Weyman A . The Committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.

    Article  CAS  Google Scholar 

  8. Devereux RB, Reichek N . Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.

    Article  CAS  Google Scholar 

  9. Ferrara LA, Vaccaro O, Cardoni O, Laurenzi M, Mancini M, Zanchetti A . Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. Am J Hypertens 2005; 18: 1282–1287.

    Article  Google Scholar 

  10. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, De Divitiis O et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251–1260.

    Article  CAS  Google Scholar 

  11. Ferrara LA, Vaccaro O, Cardoni O, Panarelli W, Laurenzi M, Zanchetti A . Is there a relationship between left ventricular mass and plasma glucose and lipids independent of body mass index? Results from the Gubbio Study. Nutr Met Cardiovac Dis 2003; 13: 126–132.

    Article  CAS  Google Scholar 

  12. Kuo LC, Quinones MA, Rokey R, Sartori M, Abinader EG, Zoghbi WA . Quantification of atrial contribution to left ventricular filling by pulsed Doppler echocardiography and the effect of age in normal and diseased hearts. Am J Cardiol 1987; 59: 1174–1178.

    Article  CAS  Google Scholar 

  13. Executive Summary. The third report of the National Cholesterol Educatiuon Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III). JAMA 2001; 285: 2486–2497.

  14. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al., American Heart Association; National Heart, Lung and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–2752.

    Article  Google Scholar 

  15. Ford ES, Giles WH, Dietz WH . Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.

    Google Scholar 

  16. Huggett RJ, Burns J, Mackintosh AF, Mary DA . Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 2004; 44: 847–852.

    Article  CAS  Google Scholar 

  17. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM et al. Obesity, regional body fat distribution and the metabolic syndrome in older men and women. Arch Intern Med 2005; 165: 777–783.

    Article  Google Scholar 

  18. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH . Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352.

    Article  CAS  Google Scholar 

  19. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP . Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.

    Article  CAS  Google Scholar 

  20. Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation 2001; 103: 2–7.

    Article  Google Scholar 

  21. Rutter MK, Parise H, Benjamin EJ, Levy D, Larson MG, Meigs JB et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003; 107: 448–454.

    Article  CAS  Google Scholar 

  22. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 1991–1998.

    Article  CAS  Google Scholar 

  23. Guida L, Celentano A, Iannuzzi R, Ferrara LA . Insulin resistance, ventricular mass and function in normoglycaemic hypertensives. Nutr Metab Cardiovasc Dis 2001; 11: 306–311.

    CAS  PubMed  Google Scholar 

  24. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004; 93: 40–44.

    Article  Google Scholar 

  25. Ferrara LA, Guida L, Ferrara F, De Luca G, Staiano L, Celentano A et al. Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome. J Hum Hypertens 2007; [E-pub ahead of print: doi:10.1038/sj.jhh.1002222].

  26. Burchfiel CM, Skelton TN, Andrew ME, Garrison RJ, Arnett DK, Jones DW et al. Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2005; 112: 819–827.

    Article  Google Scholar 

  27. Devereux RB, Casale PN, Wallerson DC, Kligfield P, Hammond IW, Liebson PR et al. Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension 1987; 9 (Part 2): 69–76.

    Google Scholar 

  28. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A, et al., On behalf of the APROS investigators. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens 2002; 20: 1307–1314.

    Article  CAS  Google Scholar 

  29. Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults. The Strong Heart Study. Circulation 2002; 105: 1928–1933.

    Article  Google Scholar 

Download references

Acknowledgements

The study was supported in part by a NIH grant and by Merck Sharp and Dohme.

Author information

Author notes

  1. O Cardoni: Deceased.

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, Federico II University of Naples, Naples, Italy

    L A Ferrara & M Mancini

  2. Ospedale di Gubbio, Gubbio, Italy

    O Cardoni

  3. Centro di Fisiologia Clinica ed Ipertensione, Università di Milano, Ospedale Maggiore and Istituto Auxologico Italiano, Milano, Italy

    A Zanchetti

Authors
  1. L A Ferrara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O Cardoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Mancini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Zanchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Gubbio Study Research Group

Corresponding author

Correspondence to L A Ferrara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrara, L., Cardoni, O., Mancini, M. et al. Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens 21, 795–801 (2007). https://doi.org/10.1038/sj.jhh.1002232

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002232

Keywords

This article is cited by

Search

Advanced search

Quick links